Clorox CO /DE/ Form 4 insider transactions

Clorox Company Director Russell J. Weiner has increased his beneficial ownership in the company by acquiring additional deferred stock units through dividend reinvestment and in lieu of director's fees.

Clorox Director Matthew J. Shattock increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and receipt of director's fees in lieu of cash.

Clorox Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and in lieu of director's fees.

Clorox Company Director Spencer C. Fleischer has increased his beneficial ownership of the company's common stock through the acquisition of additional deferred stock units via dividend reinvestment and in lieu of quarterly director's fees.

Clorox Company Director Pierre R. Breber acquired additional Deferred Stock Units through dividend reinvestment and in lieu of quarterly fees, significantly increasing his beneficial ownership.

Director Breber Pierre R purchased 4,000 shares of Clorox (CLX) at an average price of $136.5713 on May 7, 2025.

Luc Bellet, EVP and CFO of Clorox, acquired 2,704 shares of common stock at $147.91 per share on April 1, 2025, under a restricted stock unit plan.

Director Christopher J. Williams reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Russell J. Weiner reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Stephanie Plaines reports acquisition of deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Spencer C. Fleischer reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of director's fees.

Director Pierre R Breber reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of quarterly director's fees.

Chris T Hyder, an EVP at Clorox, reported a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock.

Stacey Grier, Executive Chief of Staff at Clorox, reports the withholding of shares to cover tax obligations related to vesting restricted stock.

EVP and Chief People Officer of Clorox, Kirsten Marriner, sold shares of common stock on March 10th and 11th, 2025, under a pre-planned trading program.

Director Julia Charter reports acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award.

Director A.D. David Mackay reports the acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award, increasing his holdings.

Director Esther Lee reports the acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award, increasing her holdings.

Director Russell J. Weiner reports the acquisition of deferred stock units in Clorox Co.

Director Matthew Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment, annual award, and in lieu of director's fees.

Stephanie Plaines, a director at Clorox, reported the acquisition of deferred stock units through dividend reinvestment, an annual award, and in lieu of quarterly director's fees.

Director Spencer C. Fleischer reports acquisition of Clorox deferred stock units through dividend reinvestment, annual award, and in lieu of director's fees, increasing total holdings.

Director Christopher J. Williams increased his holdings in Clorox through stock acquisitions and deferred stock unit awards.

Director Pierre R. Breber acquired deferred stock units in lieu of quarterly director's fees, to be settled in Clorox stock upon retirement or termination of service.

Clorox's Executive Vice President and Chief Operating Officer, Eric H. Reynolds, sold 283 shares of common stock to cover tax obligations related to previously granted restricted stock units.

Clorox CEO Linda Rendle sold 884 shares of company stock to cover tax obligations related to previously granted restricted stock units.

A Clorox executive, Laurene E. Peck, sold 41 shares of common stock to cover tax obligations related to previously granted restricted stock units.

EVP and CFO of Clorox, Kevin B. Jacobsen, reports disposition of shares to cover tax obligations and updates beneficial ownership.

EVP Chris T. Hyder of Clorox Co. reports disposing of 99 shares of common stock to cover employment tax obligations related to previously granted restricted stock units.